InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: None

Friday, 12/22/2017 12:06:45 PM

Friday, December 22, 2017 12:06:45 PM

Post# of 675
Keyzilen (AM-101) - TACTT3
Acute inner ear tinnitus
Phase 3

1Q 2018: Results due by 03/31/2018
Phase 3 TACTT3 enrollment resumption announced January 26, 2017 with top-line data 1Q 2018.

Buying picking up in anticipation?

In My Own Personal Opinion Of Course!